NEOSURF
NEOSURF
Approved
DIN Number
02288621
Drug Class
Human
Market Date
N/A
Company
HC
Cipla Ltd.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02288621
AIG Number0252489001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
R07AA02 NATURAL PHOSPHOLIPIDS
Product Specifications
Dosage FormSuspension
Route of AdministrationIntratracheal
AHFS Classification48:36.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
PHOSPHOLIPIDActive
Strength: 27 MG / ML
Monograph: PHOSPHOLIPID
SURFACTANT-ASSOCIATED PROTEINS SP-B AND SP-CActive
Strength: 500 MCG / ML
Monograph: SURFACTANT-ASSOCIATED PROTEINS SP-B AND SP-C